Table 1.

Referral values for morbidity rate in the IMI-CNMR study and in the international

Surgical	Indicators	Benchmark referral values
Procedure		Present study	International literature
WE	Wound infection	1.1% (0.4 to 2.7%)	4.6–8.4%a
	Wound dehiscence	2.0% (0.8 to 5.1%)	3.5–4.6%a
	Skin graft failure	unreliable	< 2%a
SLNB	Wound Infection	1.3% (0.7 to 2.5%)	2.9% (1.5 to 4.6%)b
	Wound dehiscence	0.9% (0.2 to 3.0%)	0.24–1.2%a
	Seroma	4.2% (1.5 to 11.1%)	5.1% (2.5 to 8.6%)b
LFND	Wound infection	4.1% (2.1 to 8.0%)	15.8%a
	Wound dehiscence	2.8% (0.9 to 8.6%)	3%a
	Wound infection and/or dehiscence	6.5% (2.9 to 14.0%)	21.6% (13.8 to 30.6%)c
	Seroma	15.1% (4.6 to 39.9%)	17.9% (10.3 to 27%)c

Data expressed as percentage with 95% confidence interval in parentheses

^aMorton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ; Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005 Sep;242 (3):302–11; discussion 311–3

^bMoody JA, Ali RF, Carbone AC, Singh S, Hardwicke JT. Complications of sentinel lymph node biopsy for melanoma-A systematic review of the literature. Eur J Surg Oncol. 2017;43:270–277

^cMoody JA, Botham SJ, Dahill KE, Wallace DL, Hardwicke JT. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma - A systematic review of the literature. Eur J Surg Oncol. 2017;43:1760–1767